The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

Trump teased the announcement, then Coca-Cola Co. confirmed it: a cane sugar-sweetened version of the beverage maker's ...

While traditional pharmacological interventions and advancements in surgical techniques have provided some relief, adverse drug reactions and the inherent ... endeavours to delineate the effect and ...

Pig Assay Joins Industry-Leading Catalog, Supporting Translational and Comparative Research ...

Drivers are not the only ones to blame for roadway fatalities. That's the crux of a review article in the New England Journal ...

Sarepta would need to conduct new analyses to validate the safety of Elevidys—which has had U.S. shipments paused by the ...

The Substance Abuse and Mental Health Services Administration July 28 released its latest national survey on drug use and ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

A Bloomington man was sentenced this week for one count of armed habitual criminal and four counts of unlawful possession of ...

The diabetes drug glipizide was linked to a higher risk of serious heart problems compared to dipeptidyl peptidase-4, or DPP4, inhibitors in patients with Type 2 diabetes, according to a study ...